Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This is a phase I safety and immunogenicity trial comparing high-dose (HD)trivalent
inactivated influenza vaccine (TIV) to standard dose (SD) TIV in pediatric patients with
Acute Lymphoblastic Leukemia.